AGENUS INC

AGENNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$114.2M

▲ 10.4% YoY

Net Income

-$3.1M

▲ 98.7% YoY

EPS

$0.00

▲ 100.0% YoY

Cash

$3.0M

▼ 92.6% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.